Author Correction: Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia
Authors:
Open Access
- 23 October 2023
- journal article
- correction
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1